Published financial brief
4384B
THC BIOMED INTL LTD
- As of
- 2022-07-31
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
2 data notes
- Input provenance requires review.
- One or more values are unavailable.
Exact-period record
Fundamentals
5 reported periods
| Metric | FY 20182018-07-31 | FY 20192019-07-31 | FY 20202020-07-31 | FY 20212021-07-31 | FY 20222022-07-31 |
|---|---|---|---|---|---|
| Financial statements | |||||
| RevenueUSD millions | 0.9 | 1.5 | 4.2 | 3.8 | 3.3 |
| Cost of goods soldUSD millions | 0.5 | -0 | 1.2 | 7.8 | 4.4 |
| Selling, general and administrative expenseUSD millions | 2.7 | 5.6 | 2 | 1.8 | 1.2 |
| Depreciation and amortizationUSD millions | 0.2 | 0.6 | 1 | 1 | 0.9 |
| Net incomeUSD millions | -12.5 | -12.7 | -0.2 | -6.4 | -3.1 |
| Operating profit (EBIT)USD millions | -2.4 | -4.7 | -0.1 | -6.8 | -3.3 |
| Income taxesUSD millions | 0 | 0 | 0 | 0 | 0 |
| Short-term debtUSD millions | 0.1 | 0.9 | 3 | 2.9 | 3.5 |
| Long-term debtUSD millions | 0.6 | 1.3 | 1.3 | 1.6 | 1 |
| Cash and equivalentsUSD millions | 2 | 1 | 0.8 | 0.1 | 0.5 |
| ReceivablesUSD millions | 0.1 | 0.5 | 0.3 | 0.7 | 0.5 |
| InventoryUSD millions | 1.2 | 3.5 | 6.7 | 3.2 | 2.8 |
| PayablesUSD millions | 0.6 | 1.1 | 1.3 | 1.3 | 1.1 |
| Net property, plant and equipmentUSD millions | 6.3 | 12.8 | 13.7 | 13.1 | 10.4 |
| Capital expenditureUSD millions | 5.1 | 7.2 | 1.4 | 0.4 | 0.2 |
| Operating cash flowUSD millions | -2.4 | -1.9 | 0.1 | -1 | -1.9 |
| Prepaid expensesUSD millions | —missing | —missing | —missing | —missing | —missing |
| AccrualsUSD millions | —missing | —missing | 0.2 | 0.2 | 0.2 |
| EBITDAUSD millions | -2.2 | -4.1 | 0.9 | -5.8 | -2.3 |
| Working capitalUSD millions | 2.1 | 1.9 | 2.5 | -1.7 | -2.6 |
| Working capital requirementUSD millions | 0.6 | 2.9 | 5.7 | 2.6 | 2.2 |
| Total debtUSD millions | 0.8 | 2.2 | 4.4 | 4.6 | 4.5 |
| Free cash flowUSD millions | -7.6 | -9 | -1.3 | -1.4 | -2 |
| Unlevered free cash flowUSD millions | -8 | -13.6 | -3.3 | -3.1 | -2.2 |
| Returns and ratios | |||||
| ROICratio | -34.9% | -30.2% | -0.4% | -43.3% | -25.9% |
| Pre-tax ROICratio | -34.9% | -30.2% | -0.4% | -43.3% | -25.9% |
| Effective tax rateratio | 0% | 0% | 0% | 0% | 0% |
| Revenue growthratio | 1,441.7% | 61.1% | 180.4% | -9.7% | -11.5% |
| EBIT / Revenueratio | -260.5% | -318.3% | -2% | -180.6% | -98% |
| Revenue / Invested capitalmultiple | 0.13× | 0.09× | 0.21× | 0.24× | 0.26× |
| Cogs Over Revenuesratio | 49.4% | -0.8% | 29.3% | 207.5% | 133% |
| Sga Over Revenuesratio | 289.7% | 378.5% | 48.5% | 47.2% | 37.2% |
| Da Over Revenuesratio | 21.4% | 40.6% | 24.3% | 26% | 27.8% |
| Nfa Over Revenuesratio | 681.3% | 861.7% | 328.8% | 347.8% | 311.5% |
| Wcr Over Revenuesratio | 66.3% | 193.9% | 136.7% | 68.9% | 67.2% |
| Debt Over Ebitdamultiple | —missing | —missing | 4.68× | —missing | —missing |
| St Debt Over Cashmultiple | 0.07× | 0.88× | 4.02× | 26.37× | 7.27× |
| Interest Over Ebitdamultiple | —missing | —missing | 0.39× | —missing | —missing |
| Interest Over Nocf Nicfmultiple | -0.02× | -0.01× | -0.28× | -0.31× | -0.25× |
| Nsf Over Wcrmultiple | -3.05× | -0.04× | 0.4× | 1.08× | 1.35× |
Ask this snapshot
Research assistant
4384B · annualSnapshot e4d3c8f0
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000